Previous Article | Next Article ![]()
Journal of Bacteriology, September 1998, p. 4686-4692, Vol. 180, No. 17
Department of Molecular and Cell Biology,
University of California, Berkeley, California 94708-3206
Received 9 April 1998/Accepted 29 June 1998
We found that the previously reported SS-B drug-supersusceptible
mutant of Salmonella typhimurium (S. Sukupolvi, M. Vaara, I. M. Helander, P. Viljanen, and P. H. Mäkelä, J. Bacteriol. 159:704-712, 1984) had a mutation in
the acrAB operon. Comparison of this mutant with its parent
strain and with an AcrAB-overproducing strain showed that the
activity of the AcrAB efflux pump often produced significant resistance
to
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Multidrug Efflux Pump AcrAB of Salmonella typhimurium
Excretes Only Those
-Lactam Antibiotics Containing Lipophilic
Side Chains
-lactam antibiotics in the complete absence of
-lactamase.
The effect of AcrAB activity on resistance was more pronounced with
agents containing more lipophilic side chains, suggesting that such
compounds were better substrates for this pump. This correlation is
consistent with the hypothesis that only those molecules that
become at least partially partitioned into the lipid bilayer
of the cytoplasmic membrane are captured by the AcrAB pump.
According to this mechanism, the pump successfully excretes even those
-lactams that fail to traverse the cytoplasmic membrane, because
these compounds are likely to become partitioned into the
outer leaflet of the bilayer. Even the compounds with
lipophilic side chains were shown to penetrate across the outer
membrane relatively rapidly, if the pump was inactivated genetically or
physiologically. The exclusion of such compounds, exemplified by
nafcillin, from cells of the wild-type S. typhimurium
was previously interpreted as the result of poor diffusion across
the outer membrane (H. Nikaido, Biochim. Biophys. Acta 433:118-132,
1976), but it is now recognized as the consequence of
efficient pumping out of entering antibiotics by the active efflux
process.
*
Corresponding author. Mailing address: Department of
Molecular and Cell Biology, 229 Stanley Hall, University of California, Berkeley, CA 94720-3206. Phone: (510) 642-2027. Fax: (510) 643-9290. E-mail: nhiroshi{at}uclink4.berkeley.edu.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |